Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Parkinsons Disease Drugs Market Size, Status and Forecast 2022

  • QYR2352217
  • 101 Pages
  • January 2018
  • Medical Devices
Download Sample    Get Discount   
 
This report studies the global Parkinsons Disease Drugs market, analyzes and researches the Parkinsons Disease Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like

GSK

Novartis

Boehringer Ingelheim

Teva Pharmaceutical

Abbvie

Merck

Akorn

Kyowa Hakko Kirin Pharma

Astellas Pharma

Desitin Arzneimittel

Endo Pharmaceuticals

F.Hoffmann-La Roche

H.Lundbeck

Valeant

Apokyn

Orion

Stada Arzneimittel

US WorldMeds

Valeant Pharmaceuticals

Market segment by Regions/Countries, this report covers

United States

EU

Japan

China

India

Southeast Asia

Market segment by Type, the product can be split into

Madopar

Sinemet-CR

Trastal

COMT Inhibitor

Other

Market segment by Application, Parkinsons Disease Drugs can be split into

Under 40 Years Old

40-65 Years Old

Above 65 Years Old

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Parkinsons Disease Drugs Market Size, Status and Forecast 2022

1 Industry Overview of Parkinsons Disease Drugs

1.1 Parkinsons Disease Drugs Market Overview

1.1.1 Parkinsons Disease Drugs Product Scope

1.1.2 Market Status and Outlook

1.2 Global Parkinsons Disease Drugs Market Size and Analysis by Regions

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Parkinsons Disease Drugs Market by Type

1.3.1 Madopar

1.3.2 Sinemet-CR

1.3.3 Trastal

1.3.4 COMT Inhibitor

1.3.5 Other

1.4 Parkinsons Disease Drugs Market by End Users/Application

1.4.1 Under 40 Years Old

1.4.2 40-65 Years Old

1.4.3 Above 65 Years Old

2 Global Parkinsons Disease Drugs Competition Analysis by Players

2.1 Parkinsons Disease Drugs Market Size (Value) by Players (2016 and 2017)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 GSK

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)

3.1.5 Recent Developments

3.2 Novartis

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)

3.2.5 Recent Developments

3.3 Boehringer Ingelheim

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)

3.3.5 Recent Developments

3.4 Teva Pharmaceutical

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)

3.4.5 Recent Developments

3.5 Abbvie

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)

3.5.5 Recent Developments

3.6 Merck

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)

3.6.5 Recent Developments

3.7 Akorn

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)

3.7.5 Recent Developments

3.8 Kyowa Hakko Kirin Pharma

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)

3.8.5 Recent Developments

3.9 Astellas Pharma

3.9.1 Company Profile

3.9.2 Main Business/Business Overview

3.9.3 Products, Services and Solutions

3.9.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)

3.9.5 Recent Developments

3.10 Desitin Arzneimittel

3.10.1 Company Profile

3.10.2 Main Business/Business Overview

3.10.3 Products, Services and Solutions

3.10.4 Parkinsons Disease Drugs Revenue (Value) (2012-2017)

3.10.5 Recent Developments

3.11 Endo Pharmaceuticals

3.12 F.Hoffmann-La Roche

3.13 H.Lundbeck

3.14 Valeant

3.15 Apokyn

3.16 Orion

3.17 Stada Arzneimittel

3.18 US WorldMeds

3.19 Valeant Pharmaceuticals

4 Global Parkinsons Disease Drugs Market Size by Type and Application (2012-2017)

4.1 Global Parkinsons Disease Drugs Market Size by Type (2012-2017)

4.2 Global Parkinsons Disease Drugs Market Size by Application (2012-2017)

4.3 Potential Application of Parkinsons Disease Drugs in Future

4.4 Top Consumer/End Users of Parkinsons Disease Drugs

5 United States Parkinsons Disease Drugs Development Status and Outlook

5.1 United States Parkinsons Disease Drugs Market Size (2012-2017)

5.2 United States Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Parkinsons Disease Drugs Development Status and Outlook

6.1 EU Parkinsons Disease Drugs Market Size (2012-2017)

6.2 EU Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Parkinsons Disease Drugs Development Status and Outlook

7.1 Japan Parkinsons Disease Drugs Market Size (2012-2017)

7.2 Japan Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Parkinsons Disease Drugs Development Status and Outlook

8.1 China Parkinsons Disease Drugs Market Size (2012-2017)

8.2 China Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Parkinsons Disease Drugs Development Status and Outlook

9.1 India Parkinsons Disease Drugs Market Size (2012-2017)

9.2 India Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Parkinsons Disease Drugs Development Status and Outlook

10.1 Southeast Asia Parkinsons Disease Drugs Market Size (2012-2017)

10.2 Southeast Asia Parkinsons Disease Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)

11.1 Global Parkinsons Disease Drugs Market Size (Value) by Regions (2017-2022)

11.1.1 United States Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)

11.1.2 EU Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)

11.1.3 Japan Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)

11.1.4 China Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)

11.1.5 India Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)

11.1.6 Southeast Asia Parkinsons Disease Drugs Revenue and Growth Rate (2017-2022)

11.2 Global Parkinsons Disease Drugs Market Size (Value) by Type (2017-2022)

11.3 Global Parkinsons Disease Drugs Market Size by Application (2017-2022)

12 Parkinsons Disease Drugs Market Dynamics

12.1 Parkinsons Disease Drugs Market Opportunities

12.2 Parkinsons Disease Drugs Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Parkinsons Disease Drugs Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Parkinsons Disease Drugs Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Parkinsons Disease Drugs Product Scope

Figure Global Parkinsons Disease Drugs Market Size (Million USD) (2012-2017)

Table Global Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Global Parkinsons Disease Drugs Market Share by Regions in 2016

Figure United States Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure EU Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Japan Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure China Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure India Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Figure Global Parkinsons Disease Drugs Market Share by Type in 2016

Figure Madopar Market Size (Million USD) and Growth Rate (2012-2017)

Figure Sinemet-CR Market Size (Million USD) and Growth Rate (2012-2017)

Figure Trastal Market Size (Million USD) and Growth Rate (2012-2017)

Figure COMT Inhibitor Market Size (Million USD) and Growth Rate (2012-2017)

Figure Other Market Size (Million USD) and Growth Rate (2012-2017)

Figure Global Parkinsons Disease Drugs Market Share by Application in 2016

Table Key Downstream Customer in Under 40 Years Old

Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in Under 40 Years Old (2012-2017)

Table Key Downstream Customer in 40-65 Years Old

Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in 40-65 Years Old (2012-2017)

Table Key Downstream Customer in Above 65 Years Old

Figure Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate in Above 65 Years Old (2012-2017)

Table Parkinsons Disease Drugs Market Size (Million USD) by Players (2016 and 2017)

Figure Parkinsons Disease Drugs Market Size Share by Players in 2016

Figure Parkinsons Disease Drugs Market Size Share by Players in 2017

Table GSK Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of GSK (2012-2017)

Figure GSK Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Novartis Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Novartis (2012-2017)

Figure Novartis Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Boehringer Ingelheim Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Boehringer Ingelheim (2012-2017)

Figure Boehringer Ingelheim Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Teva Pharmaceutical Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Teva Pharmaceutical (2012-2017)

Figure Teva Pharmaceutical Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Abbvie Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Abbvie (2012-2017)

Figure Abbvie Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Merck Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Merck (2012-2017)

Figure Merck Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Akorn Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Akorn (2012-2017)

Figure Akorn Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Kyowa Hakko Kirin Pharma Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Kyowa Hakko Kirin Pharma (2012-2017)

Figure Kyowa Hakko Kirin Pharma Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Astellas Pharma Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Astellas Pharma (2012-2017)

Figure Astellas Pharma Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Desitin Arzneimittel Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Desitin Arzneimittel (2012-2017)

Figure Desitin Arzneimittel Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Endo Pharmaceuticals Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Endo Pharmaceuticals (2012-2017)

Figure Endo Pharmaceuticals Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table F.Hoffmann-La Roche Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of F.Hoffmann-La Roche (2012-2017)

Figure F.Hoffmann-La Roche Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table H.Lundbeck Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of H.Lundbeck (2012-2017)

Figure H.Lundbeck Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Valeant Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Valeant (2012-2017)

Figure Valeant Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Apokyn Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Apokyn (2012-2017)

Figure Apokyn Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Orion Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Orion (2012-2017)

Figure Orion Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Stada Arzneimittel Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Stada Arzneimittel (2012-2017)

Figure Stada Arzneimittel Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table US WorldMeds Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of US WorldMeds (2012-2017)

Figure US WorldMeds Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Valeant Pharmaceuticals Basic Information List

Table Parkinsons Disease Drugs Business Revenue (Million USD) of Valeant Pharmaceuticals (2012-2017)

Figure Valeant Pharmaceuticals Parkinsons Disease Drugs Business Revenue Market Share in 2016

Table Global Parkinsons Disease Drugs Market Size (Million USD) by Type (2012-2017)

Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2012

Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2013

Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2014

Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2015

Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2016

Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2017

Table Global Parkinsons Disease Drugs Market Size (Million USD) by Application (2012-2017)

Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2012

Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2013

Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2014

Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2015

Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2016

Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2017

Table Top Consumer/End Users of Parkinsons Disease Drugs

Figure United States Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table United States Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)

Figure United States Parkinsons Disease Drugs Market Size Share by Players in 2016

Figure United States Parkinsons Disease Drugs Market Size Share by Players in 2017

Figure EU Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table EU Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)

Figure EU Parkinsons Disease Drugs Market Size Share by Players in 2016

Figure EU Parkinsons Disease Drugs Market Size Share by Players in 2017

Figure Japan Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table Japan Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)

Figure Japan Parkinsons Disease Drugs Market Size Share by Players in 2016

Figure Japan Parkinsons Disease Drugs Market Size Share by Players in 2017

Figure China Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table China Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)

Figure China Parkinsons Disease Drugs Market Size Share by Players in 2016

Figure China Parkinsons Disease Drugs Market Size Share by Players in 2017

Figure India Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table India Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)

Figure India Parkinsons Disease Drugs Market Size Share by Players in 2016

Figure India Parkinsons Disease Drugs Market Size Share by Players in 2017

Figure Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)

Table Southeast Asia Parkinsons Disease Drugs Market Size (Million USD) by Players (2012-2017)

Figure Southeast Asia Parkinsons Disease Drugs Market Size Share by Players in 2016

Figure Southeast Asia Parkinsons Disease Drugs Market Size Share by Players in 2017

Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Regions (2017-2022)

Table Global Parkinsons Disease Drugs Market Size (Million USD) by Regions (2017-2022)

Figure Global Parkinsons Disease Drugs Market Size Share by Regions in 2017

Figure Global Parkinsons Disease Drugs Market Size Share by Regions in 2022

Figure United States Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)

Figure EU Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)

Figure Japan Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)

Figure China Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)

Figure India Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)

Figure Southeast Asia Parkinsons Disease Drugs Revenue (Million USD) and Growth Rate (2017-2022)

Table Global Parkinsons Disease Drugs Market Size (Million USD) by Type (2017-2022)

Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2017

Figure Global Parkinsons Disease Drugs Market Size Share by Type in 2022

Table Global Parkinsons Disease Drugs Market Size (Million USD) by Application (2017-2022)

Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2017

Figure Global Parkinsons Disease Drugs Market Size (Million USD) by Application in 2022

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370